Mercury in Dental Amalgam, Online Retail, and the Minamata Convention on Mercury.


Journal

Environmental science & technology
ISSN: 1520-5851
Titre abrégé: Environ Sci Technol
Pays: United States
ID NLM: 0213155

Informations de publication

Date de publication:
17 11 2020
Historique:
pubmed: 4 11 2020
medline: 5 2 2021
entrez: 3 11 2020
Statut: ppublish

Résumé

The Minamata Convention on Mercury (ref. 1) is a global treaty to protect human and environmental health from adverse effects of the toxic element mercury and its compounds. During the Third Conference of Parties (COP-3) in November 2019, elimination of the use of dental amalgam in oral health care was discussed. Dental amalgam is one of the most commonly used restorative materials in oral health care due to its strength and longevity (ref. 2). However, the use of mercury in an amalgam adds to global environmental mercury pollution and can contribute to adverse health effects on humans and other organisms. The outcomes of the COP-3 meeting included a call for information on the availability at a national scale, the economic and technical feasibility of alternatives, and the associated risks or benefits. In this feature, we discuss the risks and benefits of dental amalgam, the global tracking of availability and procurement, and the implications and realities for global phase out. We suggest a better accounting of mercury use in dental amalgam is needed with sales being made only to registered practitioners via a Know Your Customer approach.

Identifiants

pubmed: 33141561
doi: 10.1021/acs.est.0c01248
doi:

Substances chimiques

Dental Amalgam 8049-85-2
Mercury FXS1BY2PGL

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

14139-14142

Auteurs

Alphin Joy (A)

IIT Hyderabad, Kandi, Sangareddy, TS 502285, India.

Asif Qureshi (A)

IIT Hyderabad, Kandi, Sangareddy, TS 502285, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH